Sunday, January 22, 2017 11:06:13 AM
In 2 years OWCP could have:
A sublingual tablet to treat Multiple Myeloma cancer.
A sublingual tablet to treat PTSD.
A sublingual tablet to treat Migraines.
A sublingual tablet to treat Fibromyalgia.
A topical cream to treat Psoriasis. (Revenue starting in Q3)
A topical cream to treat Acne.
A topical cream to treat Basal Cell Carcinoma.
A topical cream to treat Atopic Dermatitis.
Government consulting contracts. (3 contracts already signed)
Licensing agreements on their tablet, cream, and nasal spray delivery systems.
Look at the valuations of AXIM and GWPH and compare the pipelines of those companies to OWCP's pipeline. Does it really seem correct to compare OWCP with AXIM and GWPH?
The million dollar question is, knowing what is on the very bright horizon for OWCP, what will analysts' valuation be. $20 seems very reasonable to me.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM